Stock ISCO INTERNATIONAL STEM CELL CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Highlights International Stem Cell Corporation

Equities

ISCO

US4603782016

Market Closed - OTC Markets
Other stock markets
 12:22:19 2024-06-25 EDT 		5-day change 1st Jan Change
0.085 USD -5.56% Intraday chart for International Stem Cell Corporation +5.59% +37.10%
05-14 International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-28 International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Bayer says Parkinson's stem cell therapy improves symptoms in initial trial
RE
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Bayer claims early lead in Parkinson's stem cell therapy
RE
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2022
CI
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Earnings Flash (ISCO) INTERNATIONAL STEM CELL CORPORATION Reports Q4 Loss $-0.11
MT
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2021
CI
International Stem Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
International Stem Cell Corporation and S Real Estate Holdings, Llc Enters into Lease Agreement with Rehco Holdings
CI
International Stem Cell Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
International Stem Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
International Stem Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2020
CI
International Stem Cell Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020
CI
International Stem Cell Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ISCO Stock
  4. News International Stem Cell Corporation
  5. Highlights